# Session Status
_Last updated: 2026-06-13 - P0-P5 complete; full stack implemented, tested, and gate-passing_

## Phase 1 Milestone Status
| Milestone | Status | Notes |
|---|---|---|
| P0: Foundation | Complete | Scaffold + pyproject.toml pythonpath fix. |
| P1: Clinical schema | Complete | clinical/{biomarkers,thresholds,south_asian_context,disclaimers}.py + test_thresholds.py (75 tests). |
| P2: Data foundation | Complete | data/{nhanes_loader,cohort_filters,missingness,demo_cohort}.py + benchmark/percentile.py. Verified against REAL NHANES 2017-2018 files (NH-Asian cohort n=1168). 39 tests. |
| P3: FastAPI endpoints | Complete | benchmark.py + thresholds.py routers wired to P1/P2. All 17 endpoint tests pass. |
| P4: Next.js frontend | Complete | 7 MD3 components + wired pages. Type-check clean, production build 6/6 pages. Next pinned to patched 14.2.35. |
| P5: Integration + release | Complete | Smoke (32) + integration (14) + e2e (7, real uvicorn). Validation gate 8/8. Release Gate Reviewer: compliance pass. |
| Phase 2 | Deferred | Begins after physician review. See docs/PHASE2_ROADMAP.md. |

## Test Inventory (184 total, all passing)
| Suite | Tests | Scope |
|---|---|---|
| test_smoke.py | 32 | Every module imports + entry point runs |
| test_thresholds.py | 75 | All boundary cases, sources, guide, meds, SA context |
| test_cohort_filters.py | 8 | RIDRETH3==6, fasting filter boundaries |
| test_missingness.py | 6 | Counts/pct, no imputation |
| test_biomarker_mapping.py | 9 | BP averaging, renaming + real-file checks |
| test_percentile.py | 16 | Benchmark structure, demo determinism, rank |
| test_api_endpoints.py | 17 | Endpoint contract, validation, safety |
| test_integration.py | 14 | Cross-component consistency through API |
| test_e2e.py | 7 | Real uvicorn over HTTP, CORS, safety invariants |

## Critical Accuracy Fixes (against real NHANES data)
- Downloader URLs corrected to current CDC DataFiles scheme + XPORT validation (old path served HTML 404s).
- DATA_DICTIONARY: BP variables are BPXSY1-3/BPXDI1-3 (auscultatory, 2017-2018), NOT BPXOSY*/BPXODI* (2021+). PHAFSTHR is in FASTQX_J, not GLU_J.
- Demo cohort percentiles ARE the real NH-Asian percentiles; live vs demo verified identical across all 9 biomarkers.

## API Contract Sync
results.py <-> types.ts: In sync. No schema changes in P2-P5 (only router wiring + frontend consumption).

## Subagent Review Status
| Reviewer | Last Invoked | Outcome | Open Blockers |
|---|---|---|---|
| Clinical & Safety Reviewer | After P1 | Approved w/ non-blocking (1 Medium fixed) | None |
| Data & QA Auditor | After P2/P3 | Variable names verified against real files; BP/fasting corrected | None |
| Release Gate Reviewer | After P5 | Compliance pass (Literal cohort_label, required disclaimer, no-LLM guide, limitations always shown, no diagnostic language) | None |

## Open Issues
- npm audit: remaining high items require Next 16 (breaking) - deferred to Phase 2 P2.1 security.
- starlette TestClient deprecation warning (cosmetic) - httpx2 migration, Phase 2.

## Next Session Start Point
Phase 1 is functionally complete and deployable in demo mode. Next actions:
1. Deploy: frontend -> Vercel, backend -> Railway (set NEXT_PUBLIC_API_URL + ALLOWED_ORIGINS).
2. Run docs/E2E_CHECKLIST.md Tier 2 (browser) against the deployed URLs.
3. Begin Phase 2 gate: physician review (docs/PHASE2_ROADMAP.md P2.0).
